By Counterforce Health Team in Upstaza (eladocagene exuparvovec) —

How to Get Upstaza (Eladocagene Exuparvovec) Approved by Blue Cross Blue Shield in Georgia: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Upstaza Covered in Georgia

Upstaza (eladocagene exuparvovec) requires prior authorization from Blue Cross Blue Shield of Georgia. The fastest path: (1) Verify your plan covers gene therapy via member services, (2) Submit PA through Availity portal with genetic testing, failed therapy documentation, and specialist attestation, (3) If denied, file internal appeal within 180 days, then Georgia DOI external review within 60 days if needed. Standard approval takes 7-30 days; expedited review available in 72 hours for urgent cases.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Verify Coverage
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Timelines
  6. If You Need More Information
  7. If Your Request is Denied
  8. Appeals Process in Georgia
  9. Cost Assistance and Support
  10. Frequently Asked Questions
  11. Quick Reference Checklist

What This Guide Covers

This guide helps patients, families, and healthcare providers navigate getting Upstaza (eladocagene exuparvovec) approved by Blue Cross Blue Shield of Georgia (BCBSGA). Upstaza is the FDA-approved gene therapy for aromatic L-amino acid decarboxylase (AADC) deficiency, a rare genetic disorder causing severe motor dysfunction and developmental delays.

Who this helps:

  • Patients diagnosed with AADC deficiency
  • Parents and caregivers
  • Neurologists and geneticists
  • Specialty pharmacy coordinators

The approval process can feel overwhelming, but with the right documentation and approach, many families successfully obtain coverage for this life-changing treatment.

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform helps identify denial reasons and draft point-by-point rebuttals aligned to each plan's specific rules, making the appeals process more manageable for families facing complex prior authorization requirements.

Before You Start: Verify Coverage

Step 1: Confirm Your Plan Type

Call the member services number on your insurance card to verify:

  • Plan type (commercial, Marketplace, Medicare Advantage)
  • Gene therapy coverage under your specific plan
  • Specialty pharmacy network requirements
  • Medical vs. pharmacy benefit classification
Tip: BCBSGA typically covers gene therapies under the medical benefit, but verification prevents delays.

Step 2: Check Treatment Center Requirements

Critical limitation: No certified Upstaza treatment centers currently exist in Georgia. Patients must travel to designated centers like:

  • Boston Children's Hospital (Boston, MA)
  • Texas Children's Hospital (Houston, TX)

Confirm with BCBSGA whether out-of-state treatment and associated travel/lodging costs are covered under your plan.

Gather Required Documentation

Essential Documents Checklist

Medical Records:

  • Genetic testing confirming DDC gene mutations
  • CSF neurotransmitter analysis (low HVA, 5-HIAA levels)
  • Plasma AADC enzyme activity results
  • MRI or other brain imaging
  • Developmental assessments and motor function scales

Treatment History:

  • Documentation of failed standard therapies (carbidopa-levodopa, dopamine agonists, MAO inhibitors)
  • Trial duration (minimum 3 months typically required)
  • Reasons for discontinuation (lack of efficacy, intolerance)
  • Current symptom severity and progression

Administrative:

  • Insurance card and policy information
  • Prescriber information (pediatric neurologist or geneticist)
  • ICD-10 diagnosis code: E70.21 (AADC deficiency)
  • Prior authorization form from BCBSGA
Note: AADC deficiency diagnosis requires genetic testing combined with either CSF neurotransmitter analysis or plasma AADC enzyme activity testing for confirmation.

Submit Your Prior Authorization Request

Submission Methods

Preferred: Electronic Submission

  • Use BCBSGA's Availity portal for fastest processing
  • Complete forms during business hours when support is available
  • Upload all supporting documents as PDFs

Alternative: Fax Submission

  • Check your plan's PA requirements page for current fax number
  • Include cover sheet with member ID and drug name
  • Confirm receipt within 24-48 hours

Medical Necessity Letter Template

Your specialist should include these key elements:

Patient: [Name], DOB: [Date], Policy: [Number]
Diagnosis: AADC Deficiency (ICD-10: E70.21)

Clinical Summary:
- Confirmed AADC deficiency via [genetic test results/date]
- Current symptoms: [hypotonia, developmental delays, oculogyric crises]
- Failed therapies: [list with dates and outcomes]
- Disease progression without treatment: [motor decline, quality of life impact]

Treatment Rationale:
- Upstaza is the only FDA-approved disease-modifying therapy
- Patient meets eligibility criteria (age ≥18 months, confirmed diagnosis)
- Expected outcomes based on clinical trial data
- Administration plan at certified treatment center

Supporting documentation attached.

Follow-Up and Timelines

Standard Processing Times

Review Type Timeline When to Use
Standard PA 7-30 business days Routine cases
Expedited PA 72 hours Urgent medical need
Administrative screening 1-3 days Initial completeness check
Clinical evaluation 4-10 days Medical necessity review

Follow-Up Best Practices

Week 1: Confirm receipt and completeness Week 2: Check processing status via portal Week 3: Contact case manager if no decision Beyond 30 days: File complaint with Georgia DOI if no response

Sample call script: "I'm following up on prior authorization request [reference number] for Upstaza submitted on [date]. Can you provide a status update and expected decision timeline?"

If You Need More Information

Common Information Requests

Additional Clinical Data:

  • More detailed treatment history
  • Specialist consultation notes
  • Updated functional assessments
  • Peer-reviewed literature supporting treatment

Administrative Clarifications:

  • Treatment center certification verification
  • Dosing and administration details
  • Post-treatment monitoring plan

Responding Effectively

  • Submit requested information within 14 days to avoid delays
  • Include cover letter referencing original PA number
  • Highlight how additional information supports medical necessity
  • Request expedited review if clinical urgency exists

If Your Request is Denied

Common Denial Reasons and Solutions

Denial Reason How to Address
"Not medically necessary" Provide additional clinical evidence, specialist letter emphasizing disease severity
"Experimental/investigational" Reference FDA approval date (November 2024), clinical trial data
"Treatment center not in network" Request single-case agreement for out-of-state care
"Insufficient prior therapy trials" Document all failed treatments with specific dates and outcomes

Immediate Next Steps

  1. Review denial letter carefully - identify specific reasons
  2. Gather additional evidence - address each denial point
  3. Consider peer-to-peer review - specialist discusses case with medical director
  4. File internal appeal within 180 days

Appeals Process in Georgia

Internal Appeal (First Level)

Timeline: File within 180 days of denial Process:

  • Submit via BCBSGA portal or mail
  • Include denial letter and additional supporting evidence
  • Decision within 30 days (72 hours if expedited)

External Review (Second Level)

Georgia Department of Insurance External Review:

  • Deadline: Within 60 days of internal appeal denial
  • Cost: Free to consumer
  • Process: Independent medical review by specialists
  • Timeline: 30 business days (expedited available)
  • Contact: Georgia DOI Consumer Services (1-800-656-2298)
Important: External review decisions are binding on the insurance company.

When to Seek Help

Consider professional assistance from organizations like Counterforce Health when facing complex denials. Their expertise in payer-specific workflows and evidence-backed appeals can significantly improve success rates, especially for rare disease treatments requiring specialized documentation.

Cost Assistance and Support

Manufacturer Support

PTC Cares Program:

  • Copay assistance for eligible patients
  • Case management support
  • Appeals assistance
  • Contact: 1-800-979-4682 or ptccares.com

Additional Resources

  • NORD (National Organization for Rare Disorders): Financial assistance programs
  • Georgia Department of Community Health: State-specific resources
  • Georgians for a Healthy Future: Consumer advocacy and appeals guidance

Frequently Asked Questions

Q: How long does BCBSGA prior authorization take for Upstaza? A: Standard review takes 7-30 business days. Expedited review (for urgent cases) takes 72 hours.

Q: What if Upstaza isn't on my plan's formulary? A: File a formulary exception request with medical necessity documentation. Gene therapies often require individual review even if not listed.

Q: Can I get expedited approval? A: Yes, if your doctor can document that delay would seriously jeopardize your health. Submit attestation with your PA request.

Q: What happens if my internal appeal is denied? A: You can request external review through Georgia DOI within 60 days. This independent review is free and binding on the insurer.

Q: Are there treatment centers in Georgia? A: Currently no. Patients must travel to certified centers like Boston Children's Hospital or Texas Children's Hospital.

Q: Does BCBSGA cover travel expenses for out-of-state treatment? A: Coverage varies by plan. Verify with member services and request single-case agreement if needed.

Quick Reference Checklist

Before Submitting:

  • Verify gene therapy coverage with member services
  • Confirm specialist is in-network
  • Gather genetic testing and treatment history
  • Identify certified treatment center

Submission Package:

  • Completed PA form
  • Medical necessity letter from specialist
  • Genetic testing results
  • Failed therapy documentation
  • Current clinical assessments

After Submission:

  • Confirm receipt within 48 hours
  • Track via portal or reference number
  • Follow up at 2-week mark
  • Prepare appeal materials if denied

If Denied:

  • Review denial reasons carefully
  • File internal appeal within 180 days
  • Consider peer-to-peer review
  • Prepare for external review if needed

Sources & Further Reading

Disclaimer: This guide provides general information about insurance processes and should not be considered medical advice. Always consult with your healthcare provider about treatment decisions and work with your insurance company directly for plan-specific requirements. Policies and procedures may change; verify current information with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.